Filter
1649
Filtered Results: 1649
Text search:
bacteria
resistant
Featured
Recommendations
231
New Publications
404
Language
Document type
No document type
754
Guidelines
320
Studies & Reports
286
Manuals
93
Strategic & Response Plan
65
Fact sheets
55
Training Material
28
Situation Updates
10
Videos
10
Brochures
9
Infographics
9
Online Courses
7
Resource Platforms
3
Countries / Regions
India
110
South Africa
57
Global
44
Kenya
43
Ethiopia
32
Western and Central Europe
31
Tanzania
28
Nigeria
26
Africa
25
Nepal
24
Uganda
23
Latin America and the Carribbean
22
Ghana
21
Sierra Leone
18
Bangladesh
17
Zambia
16
Rwanda
16
Namibia
16
Philippines
15
Myanmar / Burma
15
Malawi
13
Liberia
12
Eswatini/ Swaziland
10
South–East Asia Region
10
Argentina
8
Eastern Europe
8
Zimbabwe
7
Peru
7
Colombia
7
Lesotho
7
Eastern Europe and Central Asia
7
Burkina Faso
6
Germany
6
Indonesia
6
Ukraine
6
Senegal
5
Congo, Democratic Republic of
5
USA
5
Cambodia
5
Botswana
5
Venezuela
5
Russia
5
Cameroon
4
Mozambique
4
Brazil
4
Western Pacific Region
4
Asia
4
Vietnam
4
Guinea
3
Haiti
3
Pakistan
3
South Sudan
3
China
3
North Macedonia
3
Bolivia
3
Madagascar
3
West and Central Africa
3
Timor Leste/ East Timor
3
Tajikistan
3
Mali
2
Guinea-Bissau
2
Iraq
2
Syria
2
Thailand
2
Benin
2
Serbia
2
Angola
2
Mexico
2
Sri Lanka
2
Chile
2
East and Southern Africa
2
Paraguay
2
Fiji
2
Laos
2
Uruguay
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Niger
1
Somalia
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Gambia
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Honduras
1
El Salvador
1
Libya
1
Guatemala
1
Nicaragua
1
Middle East and North Africa
1
Other region
1
Bhutan
1
North Korea
1
Albania
1
Armenia
1
Congo-Brazzaville
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Spain
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
543
Clinical Guidelines
216
Women & Child Health
79
Key Resources
77
Public Health
69
Pharmacy & Technologies
31
Capacity Building
27
Toolboxes
AMR
380
TB
207
HIV
98
Rapid Response
73
COVID-19
72
Planetary Health
71
Pharmacy
62
NTDs
50
Caregiver
46
Ebola
25
Cholera
20
Refugee
19
Global Health Education
17
Mental Health
14
NCDs
14
Conflict
11
Natural Hazards
11
Disability
7
Polio
7
Specific Hazards
6
Zika
5
Health Financing Toolbox
1
Policy Brief November 2021 Available in English, Spanish and Portuguese
The COVID-19 pandemic has fueled the ongoing antimicrobial resistance (AMR) global crisis due to the increase in the use of antibiotics to treat COVID-19 patients, disruptions...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in ... causing common human infections and has expanded its scope to include surveillance of antimicrobial consumption (AMC), invasive fungal infections, and a One Health surveillance model relevant to human health. To meet future challenges, it is in continuous evolution to enhance the quality and representativeness of data to inform the AMR burden accurately. As of the end of 2022, 127 countries, territories and areas participate in GLASS.
The fifth GLASS report, produced in collaboration with Member States, summarizes 2020 data on AMR rates in common bacteria from countries, territories, and areas. The report brings new features, including analyses of population testing coverage or AMR trends. For the first time, the report presents 2020 data on AMC at the national level. A new interactive dashboard allow users to explore AMR and AMC global data, country profiles and download the data.
This report marks the end of the early implementation phase of GLASS. In addition to presenting data collected through the latest data call, this report provides a summary of five years of national AMR surveillance data contributed to GLASS from its initiation, presents AMR findings in the context of progress of country participation in GLASS and in global AMR surveillance coverage and laboratory quality assurance systems at (sub)national level.
Patterns of antimicrobial consumption are presented by country with a particular focus on antibacterials. The report also presents the antimicrobial consumption according to the WHO AWaRe antibiotic classification, for penicillins and cephalosporines. From a One Health perspective, the report presents antimicrobial consumption data in the human sector expressed in tons to allow a comparison with antimicrobial consumption from other sectors (not included in this report).
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug ...ce are increasing, at alarming level. The burden of drug resistance is increasing due to the increasing cost of treatment, prolonged treatment,. That will affect patients’ health, community and social development. In the future, many
nations will be able to face the possibility of having no effective drugs to treat infectious diseases if they do not make appropriate interventions.
This course is designed for anyone with an interest in antibiotic resistance, no matter if you are a member of the public, a student, a health professional or any other expert.
Our focus is to provide an overview of antibiotic ...ce from several different angles. An important aim is to give an understanding of the mechanisms behind the increasing prevalence of antibiotic resistance worldwide, but also what the society and you as an individual can do to control and prevent further emergence and spread of antibiotic-resistant bacteria.
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in .... Antibiotic use is increasing steadily (table 1), particularly certain antibiotic classes (beta-lactam antibacterials), most notably in the more prosperous states. Resistance follows in lock-step.
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is prese...
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antib...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine ...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improve...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef...
This document provides practical guidance on planning and implementing next-generation sequencing (NGS) technology for characterization of Mycobacterium tuberculosis complex (MTBC) bacteria. The aim is to detect mutations associated with drug ...ce in the context of a surveillance system for tuberculosis (TB).
Antibiotics, also known as antimicrobial drugs, are medicines that can kill or inhibit the growth of bacteria to cure infections in people, animals and sometimes plants. Antibiotics are medicines for bacte... infections (such as pneumococcal pneumonia or staphylococcal bloodstream infections); antimicrobial drugs that are effective against viruses are usually called antiviral drugs (such as those for influenza, HIV and herpes). Not all antibiotics are active against all bacteria. There are more than 15 different classes of antibiotics that differ in their chemical structure and their action against bacteria. An antibiotic may be effective against only one or multiple types of bacteria.
In the kingdom of Bahrain, the national antibiotic committee will set the framework for the national response to AMR, especially bacterial resistance to antibiotics. It will be aligned with the Worl...
The global increase of healthcare-associated infections (HAI) presents a growing concern in healthcare worldwide. According to the European Centre for Disease Prevention and Control (ECDC), the annual number of HAI exceeds 2.6million and produces the highest estimated amou...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resista...ce will continue to develop as long as we depend on these medicines to treat bacterial infections, a continuous supply of new effective antibiotics is needed. The report identifies five key challenges that must be solved in order to achieve sustainable access for all, and charts out options for governmental action in response to each of them.
The ability of bacteria to resist the action of an antibiotic has become a recognised global problem. Antibiotic resistance severely limits the number of antibiotics available for the treatment of d...
Antibiotic resistance concerns us all – everyone can take action to address this pressing issue. There are many ways to contribute in the work to limit antibiotic resistance development and spread...
